SynapDx Obtains New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e163aab4-06fa-4366-8269-86952e58aa21&Preview=1 - Date
3/27/2013 - Company Name
SynapDx - Mailing Address
153 Cordaville Road Southborough, MA 01772 - Company Description
SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism. - Website
http://www.synapdx.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Undisclosed - Proceeds Purposes
The funding will support the ongoing clinical development of SynapDx’s breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today. - M&A Terms
- Venture Investor
The Kraft Group
